Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.9 USD | -1.20% | -8.71% | +1.43% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 50.05B |
---|---|---|---|---|---|
Net income 2024 * | 708M | Net income 2025 * | 895M | EV / Sales 2024 * | 11.9 x |
Net Debt 2024 * | 1.45B | Net Debt 2025 * | 991M | EV / Sales 2025 * | 9.91 x |
P/E ratio 2024 * |
72
x | P/E ratio 2025 * |
58.1
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | -1.20% | ||
1 week | -8.71% | ||
Current month | -1.20% | ||
1 month | -8.76% | ||
3 months | +2.66% | ||
6 months | +33.71% | ||
Current year | +1.43% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 18 M€ | +2.87% | - | |
1.04% | 16 M€ | -5.68% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 125.9 | -1.20% | 2,877,573 |
24-04-30 | 127.4 | +1.26% | 3,049,287 |
24-04-29 | 125.8 | +1.18% | 3,846,764 |
24-04-26 | 124.3 | -9.91% | 8,578,184 |
24-04-25 | 138 | +0.10% | 4,203,199 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.43% | 50.66B | |
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+11.60% | 47.64B | |
+4.60% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.06% | 25.4B | |
-1.76% | 24.71B |
- Stock Market
- Equities
- DXCM Stock